TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2496225

Group type: EXPERIMENTAL
Intervention: Encainide alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Encainide during chronic treatment with low dose quinidine (50 mg q 6 hr)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Encainide plus quinidine in extensive metabolizers
Number of subjects: 11

Group type: COMPARATOR
Intervention: Encainide plus quinidine in poor metabolizers
Number of subjects: 11
Study: 152681

Group type: EXPERIMENTAL
Intervention: Spironolactone, 200 mg daily
Number of subjects: 5
Study: 31488177

Group type: EXPERIMENTAL
Intervention: One-staged hip and knee arthroplasty (group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Two-staged hip and knee arthroplasty (group B)
Number of subjects: 42
Study: 26541328

Group type: EXPERIMENTAL
Intervention: PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme (FVOOT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PC-enriched virgin olive oil containing 500 mg PC/kg from OO (FVOO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Virgin olive oil naturally containing 80 mg PC/kg (VOO)
Number of subjects: 12
Study: 26349830

Group type: EXPERIMENTAL
Intervention: Meropenem (2 g) and RPX7009 (2 g) administered every 8 h as a 3-h intravenous infusion for a total of three doses
Number of subjects: 25
Study: 22657748

Group type: EXPERIMENTAL
Intervention: STAGE‐12 intervention
Number of subjects: 471

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 471
Study: 21306324

Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian diathermy (LOD)
Number of subjects: 44
Study: 19941250

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 16758046

Group type: EXPERIMENTAL
Intervention: Terazosin 10 mg daily and analgesic (indomethacin) for a maximum of 4 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Analgesic only (control group)
Number of subjects: 64
Study: 15660196

Group type: EXPERIMENTAL
Intervention: Sibutramine treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Hypocaloric diet and exercise
Number of subjects: 93
Study: 11318047

Group type: EXPERIMENTAL
Intervention: Modified versions of simple, go/no-go, and choice reaction time tasks
Number of subjects: 0
Study: 9388047

Group type: EXPERIMENTAL
Intervention: Nilvadipine (NIL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Temocapril (TEM)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cadralazine (CAD)
Number of subjects: 36
Study: 7955922

Group type: EXPERIMENTAL
Intervention: New untreated PT
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Treated PT
Number of subjects: 46

Group type: COMPARATOR
Intervention: Reactive thrombocytosis (RT)
Number of subjects: 46
Study: 3307653

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Shunt surgery
Number of subjects: 57
Study: 31762185

Group type: EXPERIMENTAL
Intervention: Leopold's maneuvers administered in the 28th week of pregnancy and re-administered in the 32nd and 36th weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with no intervention during the same weeks.
Number of subjects: 100
Study: 28575286

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IIV) during pregnancy
Number of subjects: 2049

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2049
Study: 25528125

Group type: EXPERIMENTAL
Intervention: Parental tobacco control intervention
Number of subjects: 17692

Group type: COMPARATOR
Intervention: Control group practices
Number of subjects: 17692
Study: 22311006

Group type: EXPERIMENTAL
Intervention: Welding fumes exposure at 1 mg/m(3) for 6 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Welding fumes exposure at 2.5 mg/m(3) for 6 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ambient air exposure (0 mg/m(3)) for 6 hours
Number of subjects: 12
Study: 21696537

Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 18359422

Group type: EXPERIMENTAL
Intervention: Patients receiving new antibiotics during the surveillance period
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Patients not on antibiotics
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Patients on no new antibiotics
Number of subjects: 739

Group type: COMPARATOR
Intervention: Pre-enrollment cultures
Number of subjects: 739

Group type: COMPARATOR
Intervention: Potential antibiotic error rates
Number of subjects: 739
Study: 16946611

Group type: EXPERIMENTAL
Intervention: Weissella cibaria CMS1 mouthrinse
Number of subjects: 0
Study: 14998732

Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Self-directed stress management
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional medical treatment
Number of subjects: 45
Study: 11716192

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2.5 mg, i.e., 100,000 IU) administered orally at three specific periods (end of September, November, and January)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no vitamin D3 treatment)
Number of subjects: 54
Study: 9173971

Group type: EXPERIMENTAL
Intervention: Resistive breathing trials with supplemental oxygen at loads of 35, 50, 75, and 90% of maximal inspiratory pressure (MIP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Resistive breathing trials without supplemental oxygen at loads of 35, 50, 75, and 90% of maximal inspiratory pressure (MIP)
Number of subjects: 6
Study: 8424419

Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg over 20 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 2434546

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol 17-propionate cream applied twice daily for 1 week
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vehicle control applied twice daily for 1 week
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol 17-propionate cream
Number of subjects: 17
Study: 28110564

Group type: EXPERIMENTAL
Intervention: Weight loss diet and exercise programmes
Number of subjects: 409

Group type: COMPARATOR
Intervention: Standard written advice (Control)
Number of subjects: 409
Study: 27302672

Group type: EXPERIMENTAL
Intervention: Chungkookjang
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 25054553

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control
Number of subjects: 6
Study: 22838225

Group type: EXPERIMENTAL
Intervention: Mandibular block
Number of subjects: 102

Group type: COMPARATOR
Intervention: Maxillary infiltration
Number of subjects: 102
Study: 20831379

Group type: EXPERIMENTAL
Intervention: Perceptual methods (narrow phonetic transcription; prosody‐voice coding)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Acoustic analysis methods
Number of subjects: 10
Study: 18412782

Group type: EXPERIMENTAL
Intervention: Dry tablet insertion of vaginal misoprostol (400 microg)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Gel form of vaginal misoprostol (400 microg)
Number of subjects: 148
Study: 12377965

Group type: EXPERIMENTAL
Intervention: 2-hour daily infusion of ara-C 500 mg/m(2)/d and 2-CdA 9 mg/m(2)/d (arm A)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ara-C 500 mg/m(2)/d and 2-CdA 9 mg/m(2)/d (arm B)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: After two courses of DAV (arm A)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: After two courses of DAV (arm B)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Coadministration of 2-CdA with ara-C
Number of subjects: 49

Group type: COMPARATOR
Intervention: Toxicity incidence between treatment arms
Number of subjects: 49
Study: 10085671

Group type: EXPERIMENTAL
Intervention: Oral Granisetron 1 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7800169

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 300
Study: 3142367

Group type: EXPERIMENTAL
Intervention: 200 micrograms of muroctasin
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 100 micrograms of muroctasin
Number of subjects: 131

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 131
Study: 30272231

Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg) once daily for 14 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Darunavir/cobicistat (800/150 mg) once daily for 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dolutegravir/darunavir/cobicistat (DTG/DRV/COBI) once daily
Number of subjects: 20
Study: 28339286

Group type: EXPERIMENTAL
Intervention: Transosseous hardware-free suture repair
Number of subjects: 69

Group type: COMPARATOR
Intervention: Single-row anchor fixation
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 69
Study: 25939897

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study: 22692116

Group type: EXPERIMENTAL
Intervention: Long duration and low intensity general warm-up (LDLI; 15 minutes at 40% V[Combining Dot Above]O2max)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Long duration and moderate intensity general warm-up (LDMI; 15 minutes at 70% V[Combining Dot Above]O2max)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Short duration and moderate intensity (SDMI; 5 minutes at 70% V[Combining Dot Above]O2max)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Short duration and low intensity (SDLI; 5 minutes at 40% V[Combining Dot Above]O2max)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (CTRL) no-GWU condition
Number of subjects: 16
Study: 21394686

Group type: EXPERIMENTAL
Intervention: Transgingival antibacterial photodynamic therapy (PDT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control site rinsed with ringer solution
Number of subjects: 19
Study: 18086243

Group type: EXPERIMENTAL
Intervention: UV‐Index (UV‐I) sensor intervention group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 17031264

Group type: EXPERIMENTAL
Intervention: Oral dipyridamole 200 mg twice daily for 24 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 12974986

Group type: EXPERIMENTAL
Intervention: Nemifitide (re-treatment)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nemifitide (initial treatment)
Number of subjects: 27
Study: 10950443

Group type: COMPARATOR
Intervention: Leg delta50 (legs only)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ldelta50 + A25 (leg delta50 plus light arm cranking at 25% of arm lactate threshold)
Number of subjects: 11
Study: 9058575

Group type: EXPERIMENTAL
Intervention: Changed memory condition (children were touched in a specific way)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Planted memory condition (children were suggested a different touch)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Erased memory condition (children were suggested no touch at all)
Number of subjects: 160
Study: 8138868

Group type: EXPERIMENTAL
Intervention: Social Skills Training
Number of subjects: 64

Group type: COMPARATOR
Intervention: School Reintegration
Number of subjects: 64
Study: 31521119

Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 345

Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 345
Study: 29709789

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 31
Study: 27046390

Group type: EXPERIMENTAL
Intervention: 40Gy/15 fractions (3-weeks)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: 27Gy/5 fractions (1-week)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: 26Gy/5 fractions (1-week)
Number of subjects: 190
Study: 25318999

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Clarithromycin combined with hydroxychloroquine
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study: 22661752

Group type: EXPERIMENTAL
Intervention: i.v. MgSO(4) at a dose of 50 mg kg(‐1) diluted in 100 ml 0.9% saline solution followed by 15 mg kg(‐1) h(‐1) for 6 h
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline at the same volume [mean (sd) 64 (10) ml]
Number of subjects: 45
Study: 20402551

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg
Number of subjects: 85

Group type: COMPARATOR
Intervention: Duloxetine 60 mg
Number of subjects: 85
Study: 18334918

Group type: EXPERIMENTAL
Intervention: CYP3A5 expressers (n=26)
Number of subjects: 136

Group type: COMPARATOR
Intervention: CYP3A5 nonexpressers (n=110)
Number of subjects: 136
Study: 17159695

Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Minor head trauma patients without hematoma (control group)
Number of subjects: 30
Study: 10801253

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg daily for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8716706

Group type: EXPERIMENTAL
Intervention: Precautionary education (group and individual education)
Number of subjects: 0
Study: 1570909

Group type: EXPERIMENTAL
Intervention: Programmed charts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blank charts
Number of subjects: 0
Study: 3874746

Group type: EXPERIMENTAL
Intervention: Toothbrush supplemented with toothpick for interproximal subgingival cleaning, with instruction to use bleeding as an interpretive device for health.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Toothbrush supplemented with toothpick for interproximal subgingival cleaning, with identical instruction in toothpick technique but without using bleeding as an interpretive device.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Toothbrush only (control group).
Number of subjects: 36
Study: 30843231

Group type: EXPERIMENTAL
Intervention: Pulsed-dye laser (PDL) treatment
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham control (no PDL treatment)
Number of subjects: 14
Study: 29681248

Group type: EXPERIMENTAL
Intervention: Complete Intervention Group (CIG)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Minimal Intervention Group (MIG)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 349
Study: 26656679

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lifestyle changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIV and lifestyle changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIV and CPAP
Number of subjects: 0
Study: 23724796

Group type: EXPERIMENTAL
Intervention: Cycling at 50% maximal heart rate reserve (HRR)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cycling at 75% maximal heart rate reserve (HRR)
Number of subjects: 18
Study: 22036837

Group type: EXPERIMENTAL
Intervention: Individualised multi-factorial lifestyle intervention
Number of subjects: 6091

Group type: COMPARATOR
Intervention: Control group (questionnaires)
Number of subjects: 6091
Study: 20426840

Group type: EXPERIMENTAL
Intervention: MEND (Mind Exercise Nutrition Do It!) program delivered to parents of children aged 2-4 years, consisting of ten 90-minute group workshops focusing on nutrition and physical activity.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Wait-list control group (not receiving the MEND program).
Number of subjects: 200
Study: 17973713

Group type: EXPERIMENTAL
Intervention: Study oil (A)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Neutral oil (B)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No intervention (C)
Number of subjects: 71
Study: 16298068

Group type: EXPERIMENTAL
Intervention: 0.5mg dexamethasone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 12087350

Group type: EXPERIMENTAL
Intervention: S21402 (250 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Captopril (50 mg)
Number of subjects: 10
Study: 10210235

Group type: EXPERIMENTAL
Intervention: Respiratory rehabilitation
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional community care
Number of subjects: 89
Study: 7872387

Group type: EXPERIMENTAL
Intervention: Topical fibronectin ophthalmic solution (3.5 mg/ml)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Vehicle drops from the fibronectin solution
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 2404368

Group type: EXPERIMENTAL
Intervention: Ceftazidime 500 mg twice daily for five days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Moxalactam 500 mg twice daily for five days
Number of subjects: 39
Study: 358727

Group type: EXPERIMENTAL
Intervention: Paracervical blocks administered to PGF2alpha-treated patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: No paracervical blocks administered to PGF2alpha-treated patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Paracervical blocks administered to saline-treated patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: No paracervical blocks administered to saline-treated patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cumulative abortion rates of PGF2alpha-treated patients with paracervical blocks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cumulative abortion rates of PGF2alpha-treated patients without paracervical blocks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Incomplete abortion rates of PGF2alpha-treated patients with paracervical blocks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Incomplete abortion rates of PGF2alpha-treated patients without paracervical blocks
Number of subjects: 100
Study: 31339827

Group type: EXPERIMENTAL
Intervention: Standard adjuvant chemotherapy (physician's choice of either cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide and doxorubicin)
Number of subjects: 633

Group type: COMPARATOR
Intervention: Capecitabine
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Standard adjuvant chemotherapy
Number of subjects: 633
Study: 28552811

Group type: EXPERIMENTAL
Intervention: Transumbilical incision (TUI)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Periumbilical incision (PUI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Participants valuing appearance of umbilicus
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Higher preoperative CSS
Number of subjects: 50
Study: 26028929

Group type: EXPERIMENTAL
Intervention: Rifaximin treatment for 4 weeks (n = 36)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Rifaximin treatment for 8 weeks (n = 43)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Rifaximin treatment for 12 weeks (n = 23)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Rifaximin treatment for 4 weeks vs 12 weeks
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Rifaximin treatment for all periods
Number of subjects: 102
Study: 23818710

Group type: EXPERIMENTAL
Intervention: Intensive treatment strategies (tight control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Less intensive treatment strategies
Number of subjects: 0
Study: 21634248

Group type: EXPERIMENTAL
Intervention: Cholecysto‐cholangiography (CCC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transcystic‐cholangiography
Number of subjects: 60
Study: 18942777

Group type: EXPERIMENTAL
Intervention: New treatment for rheumatoid arthritis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing treatments
Number of subjects: 0
Study: 16963040

Group type: EXPERIMENTAL
Intervention: Group A: recombinant hFSH from day 3 until follicles reached 13‐14 mm, then lowered to 75 IU daily, with daily injections of 200 IU of hCG and a GnRH antagonist until final maturation
Number of subjects: 323

Group type: COMPARATOR
Intervention: Group B: recombinant hFSH and a GnRH antagonist
Number of subjects: 323

Group type: COMPARATOR
Intervention: Group C: recombinant hFSH and a GnRH agonist
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 323
Study: 14599958

Group type: EXPERIMENTAL
Intervention: 13C-Hiolein diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Enzyme supplementation therapy
Number of subjects: 24
Study: 11073329

Group type: EXPERIMENTAL
Intervention: Modified tooth stain index
Number of subjects: 182

Group type: COMPARATOR
Intervention: Smoking and tea-drinking
Number of subjects: 182
Study: 8761937

Group type: EXPERIMENTAL
Intervention: Nocturnal shiftwork (four on, three off)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nocturnal shiftwork (eight on, seven off)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Diurnal living patterns
Number of subjects: 23
Study: 1533455

Group type: EXPERIMENTAL
Intervention: Amoxicillin 25 mg/kg/day divided into two doses for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Glycoproteins from Klebsiella pneumoniae (GKP) 2 tablets per day during 8 days in the 1st month and 1 tablet per day during 8 days in the following 2 months
Number of subjects: 60
Study: 3889259

Group type: EXPERIMENTAL
Intervention: Intratracheal administration of human surfactant
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional treatment with intermittent mandatory ventilation
Number of subjects: 45
Study: 31557127

Group type: EXPERIMENTAL
Intervention: Oral aromatase inhibitors (AIs)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Subcutaneous daily growth hormone (GH)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination treatment (AI/GH)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: QoLISSY questionnaire
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: KIDSCREEN questionnaire
Number of subjects: 76
Study: 30914176

Group type: EXPERIMENTAL
Intervention: Counseling + app group (IG)
Number of subjects: 833

Group type: COMPARATOR
Intervention: Counseling only group (CG)
Number of subjects: 833